|
C反应蛋白与糖尿病大血管病变的关系 |
| |
rosis,2002,164：261-267.
17 Yasojima K,Claudia S,Edith GM,et al.Generation of C-reaction protein and complement components in atherosclerotic plaquesⅢ.A J,2001,158(3)：1039-1051.
18 Pasceri V,Willerson JT,Yeh ETH.Direct proinflamrnatory effect of C-reactive protein on human endothelial cells .Circulation,2000,102(18)：2165-2168.
19 蔡文灿.糖尿病患者超敏C反应蛋白和白细胞介素6的应用研究.中华检验医学杂志,2004,27(5)：315-317.
20 Ridker PM,Cushman M,Stampfer MJ,et al.Inflammation,aspirin,and the risk of cardiovascular disease in apparently healthy men.N Engl J Med,1997,36(14):973-979.
21 Ridker PM,Buring JE,Cook NR,et al.C-reactive protein,the metabolic syndrome,and risk of incident cardiovascular events:an 8-year follow-up of 14,719 initially healthy American women.Circulation,2003,7(3):391-397.
22 Rasouli M,Kiasari AM.Interactions of serum hs-CRP with apo B,apo B/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.Clin Biochem,2006,39(10):971-977.
23 Tan KC,Chow WS,Tam SC,et al.Atorvastatin lowers C-reactive protein,and improves endothelium-dependent vasodilation in type 2 diabetes mellitus.J Clin Endocrinol Metab,2002,7(2):563-568.
24 Nissen SE,Tuzcu EM,Schoenhagen P,et al.Statin therapy,LDL cholesterol,C-reactive protein,and coronary artery disease.N Engl J Med,2005,52(1):29-38.
25 Bahia L,Aguiar LG,Villela N.Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome.Atherosclerosis,2006,Nov 2[Epub ahead of print]
(本文编辑：李倩倩)
上一页 [1] [2] [3] [4] [5] [6]
上一个医学论文： 应用加速康复外科理念指导围术期综合治疗
下一个医学论文： 口腔设备可避免的故障分析
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 中医论文 >> 正文